CRISPR Mouse Deletion NIH 3T3

- Found 3211 results

Cell cycle can be challenging due to difference introduced by sample handling, timing, and difference within the sample. Downstream instriuments to analyse cell cycle (Multicolor flow cytometry and multicolor imaging) can answer these challenges. Relevant markers can be combined with cell phenotyping markers to look at events within subpopulations of cells.

Cellular assays Cell cycle assay mouse RAW 264.7

Get tips on using PE Mouse Anti-Human CD61 Clone VI-PL2 to perform Flow cytometry Anti-bodies Human - CD61

Products BD Biosciences PE Mouse Anti-Human CD61 Clone VI-PL2

Get tips on using PE Mouse Anti-Human CD26 Clone M-A261 to perform Flow cytometry Anti-bodies Human - CD26

Products BD Biosciences PE Mouse Anti-Human CD26 Clone M-A261

Get tips on using PE-Cy™7 Mouse Anti-Human CD10 to perform Flow cytometry Anti-bodies Human - CD10

Products BD Biosciences PE-Cy™7 Mouse Anti-Human CD10

Get tips on using PE-Cy™7 Mouse Anti-Human CD56 to perform Flow cytometry Anti-bodies Human - CD56

Products BD Biosciences PE-Cy™7 Mouse Anti-Human CD56

Get tips on using PE-Cy™7 Mouse Anti-Human CD117 to perform Flow cytometry Anti-bodies Human - CD117

Products BD Biosciences PE-Cy™7 Mouse Anti-Human CD117

Get tips on using PE-Cy™7 Mouse Anti-Human CD28 to perform Flow cytometry Anti-bodies Human - CD28

Products BD Biosciences PE-Cy™7 Mouse Anti-Human CD28

Get tips on using PE Mouse Anti-Human CD30 Clone Ber-H83 to perform Flow cytometry Anti-bodies Human - CD30

Products BD Biosciences PE Mouse Anti-Human CD30 Clone Ber-H83

Get tips on using PE-Cy™7 Mouse Anti-Human CD41a to perform Flow cytometry Anti-bodies Human - CD41

Products BD Biosciences PE-Cy™7 Mouse Anti-Human CD41a

Get tips on using PerCP-Cy™5.5 Mouse Anti-Human CD19 to perform Flow cytometry Anti-bodies Human - CD19

Products BD Biosciences PerCP-Cy™5.5 Mouse Anti-Human CD19

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms